Last: | $25.41 |
---|---|
Change Percent: | 0.75% |
Open: | $25.2201 |
Close: | $25.41 |
High: | $25.548 |
Low: | $25.2201 |
Volume: | 1,395 |
Last Trade Date Time: | 03/03/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$25.41 | $25.2201 | $25.41 | $25.548 | $25.2201 | 1,395 | 03-03-2023 |
$25.571 | $25.5583 | $25.571 | $25.571 | $25.32 | 2,196 | 03-02-2023 |
$25.4992 | $25.4992 | $25.4992 | $25.4992 | $25.4992 | 318 | 03-01-2023 |
$25.4722 | $25.48 | $25.4722 | $26.09 | $25.16 | 977,746 | 02-28-2023 |
$25.32 | $25.25 | $25.32 | $25.55 | $25.22 | 24,836 | 02-27-2023 |
$25.643 | $25.21 | $25.643 | $25.67 | $25.18 | 1,415 | 02-24-2023 |
$25.4316 | $25.6699 | $25.4316 | $25.6699 | $25.425 | 1,772 | 02-23-2023 |
$25.25 | $25.73 | $25.25 | $25.8057 | $25.152 | 7,629 | 02-22-2023 |
$25.6239 | $25.3031 | $25.6239 | $25.91 | $24.92 | 7,452 | 02-21-2023 |
$25.1914 | $25.3977 | $25.1914 | $25.51 | $25.1914 | 995 | 02-20-2023 |
$25.1914 | $25.3977 | $25.1914 | $25.51 | $25.1914 | 995 | 02-17-2023 |
$25.3789 | $25.51 | $25.3789 | $25.53 | $25.23 | 5,863 | 02-16-2023 |
$25.322 | $25.4884 | $25.322 | $25.56 | $25.06 | 5,384 | 02-15-2023 |
$25.3419 | $25.54 | $25.3419 | $25.91 | $25.173 | 5,902 | 02-14-2023 |
$25.59 | $25.37 | $25.59 | $25.83 | $25.37 | 2,857 | 02-13-2023 |
$25.84 | $25.3799 | $25.84 | $25.88 | $25.155 | 5,100 | 02-10-2023 |
$25.18 | $25 | $25.18 | $25.37 | $24.97 | 4,317 | 02-09-2023 |
$25.1123 | $25.02 | $25.1123 | $25.399 | $25.02 | 9,552 | 02-08-2023 |
$25.072 | $25.05 | $25.072 | $25.2699 | $25.05 | 2,397 | 02-07-2023 |
$25.2105 | $25.16 | $25.2105 | $25.2105 | $25.16 | 2,616 | 02-06-2023 |
News, Short Squeeze, Breakout and More Instantly...
Invesco DB G10 Currency Harvest Fund Company Name:
DBV Stock Symbol:
NYSE Market:
Châtillon, France, July 30, 2024 DBV Technologies Announces Filing of 2024 Half-Year Report ― Conditions for Accessing or Consulting the Report DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutic...
Châtillon, France, July 30, 2024 DBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial Results VITESSE enrollment in peanut allergic 4-7-year-olds is on-track and recruitment is expecte...
Châtillon, France, July 29, 2024 DBV Technologies to Report Second Quarter 2024 Financial Results and Business Update on July 30, 2024 DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, toda...